- Startseite
- Company Press Releases
- Company Press Releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
19 Jul 2024 17:34 CEST |
NGE3.20%08DEC28 | AVIS DE CONVOCATION A L'ASSEMBLEE GENERALE DES PORTEURS D'OBLIGATIONS 2028 | - | General meeting / Board Meeting |
19 Jul 2024 17:30 CEST |
INVENTIVA | Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux | 20103010 Biotechnology | Other subject |
19 Jul 2024 17:30 CEST |
INVENTIVA | Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux | 20103010 Biotechnology | Other subject |
19 Jul 2024 14:00 CEST |
BIO-UV GROUP | Mutual Settlement Clears Path for Unrestricted Sale of BIO-UV Group Products in North America | 50202020 Electronic Equipment: Control and Filter | Commercial operations |
19 Jul 2024 14:00 CEST |
BIO-UV GROUP | Un Règlement Amiable Ouvre le Marché Nord-Américain aux Produits de BIO-UV Group. | 50202020 Electronic Equipment: Control and Filter | Commercial operations |
19 Jul 2024 12:50 CEST |
SCHLUMBERGER | SLB Announces Second-Quarter 2024 Results | 60101030 Oil Equipment and Services | Commercial results |
19 Jul 2024 12:24 CEST |
MERIDIA RE IV SOCIMI | Logistic warehouse financing (Barberá del Valles Warehouse) | 35102000 Diversified REITs | Other financial transaction |
19 Jul 2024 10:38 CEST |
THALES | Number of shares and voting rights - June 2024 (In French only) | 50201020 Defense | Other subject |
19 Jul 2024 10:38 CEST |
THALES | Nombre total d\'actions et droits de vote - Juin 2024 | 50201020 Defense | Other subject |
19 Jul 2024 10:22 CEST |
TIKEHAU CAPITAL | Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 12 juillet 2024 au 18 juillet 2024 | 30202010 Asset Managers and Custodians | Other subject |
19 Jul 2024 10:22 CEST |
TIKEHAU CAPITAL | Tikehau Capital: Disclosure of Shares Repurchases from 12 July 2024 to 18 July 2024 | 30202010 Asset Managers and Custodians | Other subject |
19 Jul 2024 10:18 CEST |
GROUPE JAJ | Mise à disposition des documents préparatoires à l\'AG du 30/09/24 | 40204020 Clothing and Accessories | Income |
19 Jul 2024 10:12 CEST |
GROUPE JAJ | Chiffre d\'Affaires du 1er Trimestre de l\'Exercice 2024/2025 | 40204020 Clothing and Accessories | Corporate life |
19 Jul 2024 10:03 CEST |
GROUPE JAJ | Mise à Disposition du Rapport Financier Annuel de l\'Exercice 2023/2024 sur notre site www.jaj.fr | 40204020 Clothing and Accessories | Legal |
19 Jul 2024 09:50 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Information on Document Availability | 20102015 Medical Supplies | Commercial results |
19 Jul 2024 09:50 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents | 20102015 Medical Supplies | Commercial results |
19 Jul 2024 09:39 CEST |
RAPID NUTRITION | Rapid Nutrition PLC half-year report of liquidity contract on 30/06/2024 | 45102020 Food Products | News contracts |
19 Jul 2024 09:20 CEST |
LEXIBOOK LINGUIST. | Suspension de la cotation de l’action LEXIBOOK sur Euronext Growth© à Paris | 40203010 Consumer Electronics | Other subject |
19 Jul 2024 08:15 CEST |
UNIBAIL-RODAMCO-WESTFIELD | Westfield Hamburg-Überseequartier Project Update | 35102045 Retail REITs | Other subject |
19 Jul 2024 08:00 CEST |
SEGRO PUBLIC LIMITED COMPANY | SEGRO Disposes of €327 Million Logistics Warehouse Portfolio in Italy | 35102020 Industrial REITs | Other subject |
19 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox announces attendance at upcoming conferences | 20103015 Pharmaceuticals | Meetings / events |
19 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom : Evolution de la gouvernance | 60101010 Oil: Crude Producers | Journal / appointments |
19 Jul 2024 07:30 CEST |
AXWAY SOFTWARE | Axway Software:Half-Year Performance In Line With Annual Targets | 10101015 Software | Sales |
19 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox : Participation aux prochaines conférences | 20103015 Pharmaceuticals | Meetings / events |
19 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom: Changes in Governance | 60101010 Oil: Crude Producers | Journal / appointments |
19 Jul 2024 07:30 CEST |
AXWAY SOFTWARE | Axway Software :Performance semestrielle conforme aux objectifs annuels | 10101015 Software | Sales |
19 Jul 2024 07:00 CEST |
FORSEE POWER | Bilan semestriel du contrat de liquidité de la société FORSEE POWER | 50202010 Electrical Components | Other subject |
19 Jul 2024 07:00 CEST |
FORSEE POWER | Half-Year Liquidity Contract Statement for FORSEE POWER | 50202010 Electrical Components | Other subject |
19 Jul 2024 07:00 CEST |
EMEIS | emeis: Half-year review (H1 2024) of the liquidity agreement entered into with Natixis ODDO BHF | 20101010 Health Care Facilities | Other subject |
19 Jul 2024 07:00 CEST |
EMEIS | emeis : Bilan semestriel (S1 2024) du contrat de liquidité conclu avec Natixis ODDO BHF | 20101010 Health Care Facilities | Other subject |
18 Jul 2024 23:00 CEST |
CASINO GUICHARD | Casino Group Communication | 45201010 Food Retailers and Wholesalers | New |
18 Jul 2024 23:00 CEST |
CASINO GUICHARD | Communication du groupe Casino | 45201010 Food Retailers and Wholesalers | New |
18 Jul 2024 19:05 CEST |
IKONISYS | Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé | 20102010 Medical Equipment | Share introduction and issues |
18 Jul 2024 19:05 CEST |
IKONISYS | Ikonisys Completed a Capital Increase Through a Private Placement | 20102010 Medical Equipment | Share introduction and issues |
18 Jul 2024 18:45 CEST |
WALLIX | Hyper croissance maintenue des revenus récurrents au 1er semestre 2024 | 10101015 Software | Legal |
18 Jul 2024 18:45 CEST |
WALLIX | Sustained hypergrowth in recurring business in H1 2024 | 10101015 Software | Legal |
18 Jul 2024 18:44 CEST |
INTEGRAGEN | IntegraGen: First-Half 2024 Sales of €4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of €2.8m | 20103010 Biotechnology | Sales |
18 Jul 2024 18:44 CEST |
INTEGRAGEN | IntegraGen : Chiffre d’affaires de 4,5 M€ au premier semestre 2024, en hausse de 6% sur le périmètre hors SeqOIA et position de trésorerie de 2,8 M€ | 20103010 Biotechnology | Sales |
18 Jul 2024 18:30 CEST |
SARTORIUS STEDIM BIOTECH | Résultats de Sartorius Stedim Biotech pour le premier semestre 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:30 CEST |
SARTORIUS STEDIM BIOTECH | Half-year results 2024 of SartoriusStedimBiotech | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:30 CEST |
ADVICENNE | Advicenne Announces an 8.8% Increase in Gross Sales for H1 2024 and Provides an Update on Its Activities | 20103010 Biotechnology | Sales |
18 Jul 2024 18:30 CEST |
ADVICENNE | Advicenne annonce une progression de 8,8% des ventes brutes au S1 2024 et fait le point sur ses activités | 20103010 Biotechnology | Sales |
18 Jul 2024 18:28 CEST |
FORSEE POWER | Forsee Power publie son 5ème rapport de développement durableet l’intégralité de son empreinte carbone | 50202010 Electrical Components | Corporate life |
18 Jul 2024 18:28 CEST |
FORSEE POWER | Forsee Power Publishes its 5th Sustainability Report and Its Complete Carbon Footprint | 50202010 Electrical Components | Corporate life |
18 Jul 2024 18:21 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:21 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Sartorius Stedim Biotech ajuste ses prévisions pour l’exercice 2024 et présente ses résultats pur le premier semestre 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:17 CEST |
VRANKEN-POMMERY | Vranken-Pommery Monopole - 2024 First-Half Turnover- Consolidated turnover € 108 million (-5,8%) First half on track in a declining market | 45101015 Distillers and Vintners | Share history |
18 Jul 2024 18:17 CEST |
VRANKEN-POMMERY | VRANKEN-POMMERY MONOPOLE - CHIFFRE D'AFFAIRES DU 1ER SEMESTRE 2024 : Chiffre d’affaires de 108 M€ (-5,8%) Premier semestre préservé dans un marché en baisse | 45101015 Distillers and Vintners | Share history |
18 Jul 2024 18:00 CEST |
BIOSYNEX | BIOSYNEX SA: CA DU S1 2024 EN CROISSANCE : 53,8 M€ (+26% DONT +6% ORGANIQUE) - FORTE CONTRIBUTION DES ACQUISITIONS ET MONTEE EN PUISSANCE DES FILIALES AMERICAINES | 20102010 Medical Equipment | Sales |
18 Jul 2024 18:00 CEST |
I2S | i2S : Chiffre d\'affaires S1 2024 | 50202025 Electronic Equipment: Gauges and Meters | General meeting / Board Meeting |